Browse Items (35 total)
- Tags: File T M Jr
The challenge of SARS: a clinical review.
Tags: 2004, Department of Internal Medicine, File T M Jr, Infection Control, Journal of Respiratory Diseases, NEOMED College of Medicine, Severe Acute Respiratory Syndrome – Diagnosis, Severe Acute Respiratory Syndrome – Epidemiology, Severe Acute Respiratory Syndrome – Radiography, Severe Acute Respiratory Syndrome – Symptoms
International guidelines for the treatment of community-acquired pneumonia in adults: the role of macrolides.
Tags: 2003, Antibiotics, Clinical Trials, Community-Acquired Infections – Drug Therapy, Community-Acquired Infections – Etiology, Department of Internal Medicine, Drug Resistance, Drugs, File T M Jr, Immune System – Drug Effects, Inpatients, Macrolide – Pharmacodynamics, Macrolide – Therapeutic Use, Methicillin Resistance, Microbial, NEOMED College of Medicine, Nonexperimental Studies, Outpatients, Pneumonia – Drug Therapy, Pneumonia – Etiology, Practice Guidelines, Risk Assessment, Streptococcal Infections – Drug Therapy, Tan J S
Guidelines for empiric antimicrobial prescribing in community-acquired pneumonia.
Tags: 2004, Antibiotics, Antibiotics – Administration and Dosage, Antiinfective Agents, Bacterial – Drug Therapy, Blasi F, Canada, Chest, Chidiac C, Community-Acquired Infections – Drug Therapy, Comparative Studies, Department of Internal Medicine, Drug Resistance, Europe, File T M Jr, Fluoroquinolone – Therapeutic Use, Garau J, Klugman K, Lactam – Therapeutic Use, Lode H, Lonks JR, Macrolide – Therapeutic Use, Mandell L, Microbial, NEOMED College of Medicine, Pneumonia, Practice Guidelines, Ramirez J, United States, Yu V
Evolution of amoxicillin/clavulanate in the treatment of adults with acute bacterial rhinosinusitis and community-acquired pneumonia in response to antimicrobial-resistance patterns.
Tags: 2004, Antibiotics, Bacteria – Drug Effects, Benninger MS, Clinics in laboratory medicine, Combined – Therapeutic Use, Community-Acquired Infections – Drug Therapy, Community-Acquired Infections – Microbiology, Department of Internal Medicine, Drug Resistance, File T M Jr, Jacobs MR, Microbial, Microbial Culture and Sensitivity Tests, NEOMED College of Medicine, Pneumonia – Drug Therapy, Pneumonia – Microbiology, Rhinosinusitis – Drug Therapy, Rhinosinusitis – Microbiology
Community-acquired pneumonia.
Tags: 2003, Antibiotics – Therapeutic Use, Bacterial, Bacterial – Diagnosis, Bacterial – Drug Therapy, Bacterial – Microbiology, Bacterial – Prevention and Control, Community-Acquired Infections, Community-Acquired Infections – Diagnosis, Community-Acquired Infections – Drug Therapy, Community-Acquired Infections – Microbiology, Community-Acquired Infections – Prevention and Control, Department of Internal Medicine, Disease Progression, Drug Resistance, File T M Jr, Immunocompetence, Lancet, Microbial, NEOMED College of Medicine, Pneumonia, Severity of Illness, Streptococcus – Drug Effects, Vaccines – Therapeutic Use
A new dosing paradigm: high-dose, short-course fluoroquinolone therapy for community-acquired pneumonia.
Tags: 2003, Antiinfective Agents, Clinical cornerstone, Department of Internal Medicine, File T M Jr, Fluoroquinolone, Fluoroquinolone – Administration and Dosage, Fluoroquinolone – Economics, Fluoroquinolone – Pharmacodynamics, Fluoroquinolone – Therapeutic Use, NEOMED College of Medicine, Pneumonia – Drug Therapy
Community-acquired pneumonia: what's needed for accurate diagnosis. Symposium: first of five articles on pneumonia.
Treating CAP caused by penicillin-resistant S pneumoniae.
Community-acquired pneumonia: recent guidelines for therapy.
Community-acquired pneumonia: highlights of recent guidelines: how new recommendations may affect your practice.
Clinical implications of 750 mg, 5-day levofloxacin for the treatment of community-acquired pneumonia.
Tags: 2004, Adult, Chi Square Test, Community-Acquired Infections – Drug Therapy, Current Medical Research & Opinion, Department of Internal Medicine, Double-Blind Studies, Female, File T M Jr, Funding Source, Human, Kaplan-Meier Estimator, Khashab MM, Log-Rank Test, Male, McNemar's Test, Milkovich G, NEOMED College of Medicine, Ofloxacin – Administration and Dosage, Pneumonia – Drug Therapy, Random Assignment, Retrospective Design, T-Tests, Tennenberg AM, Xiang JX, Zadeikis N
New Diagnostic Tests for Pneumonia: What is Their Role in Clinical Practice?
Tags: 2011, Antigens, Bacterial – Diagnosis, Bacterial – Metabolism, Bacterial – Urine, Calcitonin – Blood, Clinics in chest medicine, Community-Acquired Infections, Community-Acquired Infections – Diagnosis, Community-Acquired Infections – Metabolism, Community-Acquired Infections – Microbiology, Department of Internal Medicine, File T M Jr, NEOMED College of Medicine, Nucleic Acid Amplification Techniques, Pneumonia, Polymerase Chain Reaction, Protein Precursors – Blood, Viral – Diagnosis, Viral – Metabolism
Urinary tract infections in obstetrics and gynecology.
Tags: 1990, Anti-Bacterial Agents/pharmacology/*therapeutic use, Department of Internal Medicine, Drug Resistance, Escherichia coli/drug effects, Female, File T M Jr, Humans, Lactams, Microbial, NEOMED College of Medicine, Pregnancy, Quinolones/therapeutic use, Tan J S, The Journal of reproductive medicine, Urinary Tract Infections/*drug therapy
Management of staphylococcal and streptococcal infections.
Tags: *Staphylococcal Infections/diagnosis/epidemiology/microbiology/therapy, *Streptococcal Infections/complications/diagnosis/microbiology/therapy, 1996, Anti-Bacterial Agents/pharmacology/therapeutic use, Clinics in podiatric medicine and surgery, Department of Internal Medicine, Female, File T M Jr, Humans, Male, NEOMED College of Medicine, Staphylococcus aureus, Streptococcus agalactiae, Streptococcus pyogenes, Tan J S
Ambulatory management of lower respiratory tract infections.
Tags: 1991, American family physician, Anti-Bacterial Agents/*therapeutic use, Bacterial Infections/drug therapy, Department of Internal Medicine, File T M Jr, Humans, Legionnaires' Disease/diagnosis, Mycoplasma/diagnosis, NEOMED College of Medicine, Pneumonia, Pneumonia/*diagnosis/*drug therapy, Tan J S, Thomson R B Jr
Treatment of skin and soft-tissue infections.
Tags: 1995, American journal of surgery, Bacterial Infections/complications/drug therapy/surgery/*therapy, beta-Lactamase Inhibitors, Department of Internal Medicine, Drug Combinations, Fasciitis/therapy, File T M Jr, Humans, Necrosis, NEOMED College of Medicine, Penicillanic Acid/analogs & derivatives/therapeutic use, Piperacillin/therapeutic use, Skin Diseases/complications/drug therapy/surgery/*therapy, Soft Tissue Infections/complications/drug therapy/surgery/*therapy, Surgical Wound Infection/microbiology, Tan J S, Tazobactam
Infectious complications in diabetic patients.
Tags: *Diabetes Complications, 1997, Candidiasis/complications/therapy, Cholecystitis/complications/therapy, Current therapy in endocrinology and metabolism, Department of Internal Medicine, File T M Jr, Humans, Infection/*complications/*therapy, Infectious/complications/therapy, NEOMED College of Medicine, Respiratory Tract Infections/complications/therapy, Skin Diseases, Tan J S, Urinary Tract Infections/complications/therapy
Infectious complications in diabetic patients.
Tags: *Diabetes Complications, 1994, Anti-Bacterial Agents/therapeutic use, Antifungal Agents/therapeutic use, Bacterial Infections/complications/*drug therapy/epidemiology, Candidiasis/complications/*drug therapy/epidemiology, Cholecystitis/complications/epidemiology/therapy, Current therapy in endocrinology and metabolism, Department of Internal Medicine, Female, File T M Jr, Humans, Incidence, Infectious/complications/*drug therapy/epidemiology, Male, Morbidity, NEOMED College of Medicine, Respiratory Tract Infections/complications/*drug therapy/epidemiology, Skin Diseases, Tan J S, Urinary Tract Infections/complications/*drug therapy/epidemiology
Community-acquired pneumonia. What's needed for accurate diagnosis.
Treatment of bacteriuria in pregnancy.
Overview of resistance in the 1990s.
Optimal treatment strategies for community-acquired pneumonia: non-responders to conventional regimens.
Tags: 2001, Anti-Infective Agents/therapeutic use, Chemotherapy, Community-Acquired Infections/drug therapy/microbiology/pathology, Department of Internal Medicine, Drug Resistance, Female, File T M Jr, Humans, Male, Microbial, NEOMED College of Medicine, Ofloxacin/therapeutic use, Pneumonia/*drug therapy/etiology/pathology, Practice Guidelines as Topic, Suppuration/drug therapy/pathology, Treatment Failure
Clinical implications and treatment of multiresistant Streptococcus pneumoniae pneumonia.
Tags: 2006, Anti-Infective Agents/*therapeutic use, Bacterial, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, Community-Acquired Infections/*drug therapy/economics/*microbiology, Department of Internal Medicine, Drug Resistance, File T M Jr, Fluoroquinolones/*therapeutic use, Humans, Ketolides/therapeutic use, Multiple, NEOMED College of Medicine, Pneumococcal/*drug therapy/economics/*microbiology, Pneumonia, Streptococcus pneumoniae/*growth & development
Incidence, etiologic pathogens, and diagnostic testing of community-acquired pneumonia.
Tags: 1997, AIDS-Related Opportunistic Infections/diagnosis/microbiology, Community-Acquired Infections/diagnosis/epidemiology/microbiology, Current opinion in pulmonary medicine, Department of Internal Medicine, File T M Jr, Humans, NEOMED College of Medicine, Pneumonia/diagnosis/epidemiology/*microbiology, Tan J S
A multicenter, randomized study comparing the efficacy and safety of intravenous and/or oral levofloxacin versus ceftriaxone and/or cefuroxime axetil in treatment of adults with community-acquired pneumonia.
Tags: *Levofloxacin, 1997, 80 and over, Administration, Adolescent, Adult, Aged, Anti-Infective Agents/adverse effects/*therapeutic use, Antimicrobial agents and chemotherapy, Bacterial/*drug therapy/microbiology, Ceftriaxone/adverse effects/*therapeutic use, Cefuroxime/adverse effects/*analogs & derivatives/therapeutic use, Cephalosporins/adverse effects/*therapeutic use, Combination, Community-Acquired Infections/drug therapy/microbiology, Department of Internal Medicine, Drug Therapy, Dunbar L, Female, File T M Jr, Humans, Injections, Intravenous, Kohler R, Kojak C, Male, Middle Aged, NEOMED College of Medicine, Ofloxacin/adverse effects/*therapeutic use, Oral, Player R, Pneumonia, Prodrugs/adverse effects/*therapeutic use, Prospective Studies, Rubin A, Segreti J, Treatment Outcome, Williams R R
Can aggressive treatment of diabetic foot infections reduce the need for above-ankle amputation?
Tags: 1996, 80 and over, Adult, Aged, Amputation, Ankle/*surgery, Bacteremia/complications/microbiology/*therapy, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, Department of Internal Medicine, Diabetic Foot/complications/microbiology/*therapy, Female, File T M Jr, Flanagan J P, Friedman N M, Hazelton-Miller C, Humans, Male, Middle Aged, NEOMED College of Medicine, Retrospective Studies, Tan J S, Treatment Outcome
Clinical characteristics of Chlamydia pneumoniae infection as the sole cause of community-acquired pneumonia.
Tags: *Chlamydophila pneumoniae/immunology, 1999, 80 and over, Adult, Aged, Antibodies, Bacterial/blood, Breiman R F, Chlamydia Infections/blood/immunology/*microbiology/*physiopathology, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, Community-Acquired Infections/blood/immunology/*microbiology/physiopathology, Department of Internal Medicine, Female, File T M Jr, Humans, Male, Middle Aged, NEOMED College of Medicine, Plouffe J F Jr, Pneumonia/blood/immunology/microbiology/*physiopathology, Skelton S K
Chlamydia pneumoniae pneumonia.
Diagnosis and treatment of diabetic foot infections.
Tags: 1999, Anti-Bacterial Agents/*therapeutic use, Bacterial Infections/*diagnostic imaging/*drug therapy, Bailliere's best practice & research. Clinical rheumatology, Department of Internal Medicine, Diabetic Foot/*microbiology, File T M Jr, Humans, NEOMED College of Medicine, Radiography, Tan J S
The role of atypical pathogens: Mycoplasma pneumoniae, Chlamydia pneumoniae, and Legionella pneumophila in respiratory infection.
Tags: *Chlamydophila pneumoniae, *Legionella pneumophila, *Mycoplasma pneumoniae, 1998, Anti-Bacterial Agents/therapeutic use, Antigens, Bacterial/analysis, Bacterial/diagnosis/epidemiology/*microbiology/therapy, Chlamydia Infections/diagnosis/epidemiology/*microbiology/therapy, Department of Internal Medicine, File T M Jr, Humans, Infectious disease clinics of North America, Legionnaires' Disease/diagnosis/epidemiology/*microbiology/therapy, Mycoplasma/diagnosis/epidemiology/microbiology/therapy, NEOMED College of Medicine, Plouffe J F, Pneumonia, Prevalence, Tan J S
Antipseudomonal penicillins.
Tags: 1995, Anti-Bacterial Agents/pharmacology, Department of Internal Medicine, Drug Resistance, File T M Jr, Humans, Microbial, Microbial Sensitivity Tests, NEOMED College of Medicine, Penicillins/adverse effects/pharmacokinetics/*therapeutic use, Pseudomonas Infections/*drug therapy, Pseudomonas/*drug effects, Tan J S, The Medical clinics of North America
Group A streptococcus necrotizing fasciitis.
Tags: *Fasciitis, 2000, 80 and over, Adult, Aged, Anti-Bacterial Agents/therapeutic use, Causality, Comprehensive therapy, Debridement, Department of Internal Medicine, Female, File T M Jr, Humans, Immunoglobulins, Intravenous/therapeutic use, Male, Middle Aged, Necrotizing/diagnosis/epidemiology/physiopathology/therapy, NEOMED College of Medicine, Practice Guidelines as Topic, Tan J S